FDA Closes Potential Food Additive Option In Warnings To Supplement Firms
Executive Summary
Six warnings to firms marketing products containing DMHA mark a change in the agency's supplement market oversight with explanation that non-dietary ingredients that have not been approved for use in food are deemed unsafe and are not allowed for use in supplements under an exemption for food additives Other three firms FDA warned were advised the ingredient phenibut found in their products also isn't eligible for use in supplements.
You may also be interested in...
DMHA Gets FDA Attention At Alternative Labs, CBD Noticed While There
Warning doesn't reference any noncompliant claims for CBD-labeled Green Roads, but FDA explains the basis for which it has stated for two years it could warn every firm marketing products that are labeled as or found containing CBD.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.
Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws
HiSmile appeals NAD recommendation following review on P&G challenge to discontinue ad claims on its website and in social media videos stating peroxide-containing whitening products are “painful” or cause pain, break down and impact gums and teeth, or “damage” gums.